BP Spot Treatment by Skin PS Brands / Cosmetic Solutions BP Spot Treatment

BP Spot Treatment by

Drug Labeling and Warnings

BP Spot Treatment by is a Otc medication manufactured, distributed, or labeled by Skin PS Brands, Cosmetic Solutions. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BP SPOT TREATMENT- spot treatment lotion 
Skin PS Brands

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

BP Spot Treatment

Active Ingredient

Benzoyl Peroxide 10.0%

Purpose

Acne Treatment

Use

for the management of acne.

Warnings

For external use only.

When using this product

  • Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with eyes, lips and mouth
  • avoid contact with hair and dyed fabrics, which may be bleached by this product
  • Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

Do not use if you

  • have very sensitive skin
  • are sensitive to Benzoyl Peroxide

Stop use and ask a doctor if

irritation becomes severe.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • clean skin thoroughly before applying this product
  • cover the entire affected area with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
  • Sensitivity Test for a New User:

Apply product sparingly to one or two small affected areas during the first 3 days. if no discomfort occurs, follow the directions stated above.

Inactive Ingredients

Water, Caprylic/Capric Triglyceride, Propanediol, Glycerin, Dimethicone, Glyceryl Oleate, Glyceryl Stearate, PEG-100 Stearate, Isosorbide Disunflowerseedate, Sodium Hyaluronate, Octyldodecyl PCA, Stearic Acid, Steareth-21, Cucumis Sativus Fruit Extract, Allantoin, Polysorbate 60, Sodium Citrate, Polyhydroxystearic Acid, Panethol, Carbomer, Titanium Dioxide, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Triethanolamine, Phenoxyethanol, Diethylhexyl Sodium Sulfosuccinate, Ethylhexylglycerin, Tocopheryl Acetate, Aluminum Stearate, Alumina, Sorbitan Isostearate, Citric Acid, Sodium Hydroxide.

How to use:

Prep by cleansing skin. Apply a thin layer to the affected area. Reapply 1 to 3 times daily, as needed.

Questions or comments?

Visit us at slmdskincare.com

@slmdskincare

Distributed by Skin PS Brands

Culver City, CA 90232

Made in USA

SLMD

Sandra Lee MD

Skin Care by Dr. Pimple Popper

BP Spot Treatment

10% Benzoyl Peroxide

Acne Treatment

0.5 fl. oz. / 15 mL

Unit Carton:

BP Unit Carton

Primary Unit:

BP Primary

BP SPOT TREATMENT 
spot treatment lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 73318-1006
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE100 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
ALLANTOIN (UNII: 344S277G0Z)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PROPANEDIOL (UNII: 5965N8W85T)  
GLYCERIN (UNII: PDC6A3C0OX)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
GLYCERYL OLEATE (UNII: 4PC054V79P)  
GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
PEG-100 STEARATE (UNII: YD01N1999R)  
WATER (UNII: 059QF0KO0R)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
2-OCTYLDODECYL 5-OXO-L-PROLINATE (UNII: E25TY46YTD)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
STEARETH-21 (UNII: 53J3F32P58)  
CUCUMBER (UNII: YY7C30VXJT)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
SORBITAN ISOSTEARATE (UNII: 01S2G2C1E4)  
POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)  
PANTHENOL (UNII: WV9CM0O67Z)  
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
TROLAMINE (UNII: 9O3K93S3TK)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
CARBOMER INTERPOLYMER TYPE A (55000 CPS) (UNII: 59TL3WG5CO)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
DOCUSATE SODIUM (UNII: F05Q2T2JA0)  
ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 73318-1006-51 in 1 CARTON06/08/2021
115 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM00606/08/202104/01/2023
Labeler - Skin PS Brands (081085221)
Registrant - Skin PS Brands (081085221)
Establishment
NameAddressID/FEIBusiness Operations
Cosmetic Solutions807907928manufacture(73318-1006)

Revised: 9/2023
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.